62 days to first decision for reviewed manuscripts only
34 days to first decision for all manuscripts
79 days from submission to acceptance
13 days from acceptance to publication
The role of autophagy in the cytotoxicity induced by trastuzumab emtansine (T-DM1) in HER2-positive breast cancer cells
Trastuzumab emtansine (T-DM1), an antibody–drug conjugate (ADC) of trastuzumab and cytotoxic agent emtansine (DM1), has been approved for the therapy of metastatic HER2-positive breast cancer after prior treat...
Citation: AMB Express 2020 10:107